Estelle M Everett1,2,3, Timothy P Copeland4, Tannaz Moin1,2,5, Lauren E Wisk2. 1. Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA. 2. Division of General Internal Medicine & Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA. 3. VA Greater Los Angeles Healthcare System, Los Angeles, California, USA. 4. Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California, USA. 5. HSR&D Center for the Study of Healthcare Innovation, Implementation & Policy, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
Abstract
BACKGROUND AND OBJECTIVES: Diabetic ketoacidosis (DKA) rates in the United States are rising. Prior studies suggest higher rates in younger populations, but no studies have evaluated national trends in pediatric populations and differences by subgroups. As such, we sought to examine national trends in pediatric DKA. METHODS: We used the 2006, 2009, 2012, and 2016 Kids' Inpatient Database to identify pediatric DKA admissions among a nationally representative sample of admissions of youth ≤20 years old. We estimate DKA admission per 10 000 admissions and per 10 000 population, charges, length of stay (LOS), and trends over time among all hospitalizations and by demographic subgroups. Regression models were used to evaluate differences in DKA rates within subgroups overtime. RESULTS: Between 2006 and 2016, there were 149 535 admissions for DKA. Unadjusted DKA rate per admission increased from 120.5 (95% CI, 115.9-125.2) in 2006 to 217.7 (95% CI, 208.3-227.5) in 2016. The mean charge per admission increased from $14 548 (95% CI, $13 971-$15 125) in 2006 to $20 997 (95% CI, $19 973-$22 022) in 2016, whereas mean LOS decreased from 2.51 (95% CI, 2.45-2.57) to 2.28 (95% CI, 2.23-2.33) days. Higher DKA rates occurred among 18- to 20-year-old females, Black youth, without private insurance, with lower incomes, and from nonurban areas. Young adults, men, those without private insurance, and from nonurban areas had greater increases in DKA rates across time. CONCLUSIONS: Pediatric DKA admissions have risen by 40% in the United States and vulnerable subgroups remain at highest risk. Further studies should characterize the challenges experienced by these groups to inform interventions to mitigate their DKA risk and to address the rising DKA rates nationally.
BACKGROUND AND OBJECTIVES: Diabetic ketoacidosis (DKA) rates in the United States are rising. Prior studies suggest higher rates in younger populations, but no studies have evaluated national trends in pediatric populations and differences by subgroups. As such, we sought to examine national trends in pediatric DKA. METHODS: We used the 2006, 2009, 2012, and 2016 Kids' Inpatient Database to identify pediatric DKA admissions among a nationally representative sample of admissions of youth ≤20 years old. We estimate DKA admission per 10 000 admissions and per 10 000 population, charges, length of stay (LOS), and trends over time among all hospitalizations and by demographic subgroups. Regression models were used to evaluate differences in DKA rates within subgroups overtime. RESULTS: Between 2006 and 2016, there were 149 535 admissions for DKA. Unadjusted DKA rate per admission increased from 120.5 (95% CI, 115.9-125.2) in 2006 to 217.7 (95% CI, 208.3-227.5) in 2016. The mean charge per admission increased from $14 548 (95% CI, $13 971-$15 125) in 2006 to $20 997 (95% CI, $19 973-$22 022) in 2016, whereas mean LOS decreased from 2.51 (95% CI, 2.45-2.57) to 2.28 (95% CI, 2.23-2.33) days. Higher DKA rates occurred among 18- to 20-year-old females, Black youth, without private insurance, with lower incomes, and from nonurban areas. Young adults, men, those without private insurance, and from nonurban areas had greater increases in DKA rates across time. CONCLUSIONS: Pediatric DKA admissions have risen by 40% in the United States and vulnerable subgroups remain at highest risk. Further studies should characterize the challenges experienced by these groups to inform interventions to mitigate their DKA risk and to address the rising DKA rates nationally.
Authors: Dana Dabelea; Arleta Rewers; Jeanette M Stafford; Debra A Standiford; Jean M Lawrence; Sharon Saydah; Giuseppina Imperatore; Ralph B D'Agostino; Elizabeth J Mayer-Davis; Catherine Pihoker Journal: Pediatrics Date: 2014-03-31 Impact factor: 7.124
Authors: Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane Journal: Diabetes Care Date: 2015-06 Impact factor: 19.112
Authors: Steven M Willi; Kellee M Miller; Linda A DiMeglio; Georgeanna J Klingensmith; Jill H Simmons; William V Tamborlane; Kristen J Nadeau; Julie M Kittelsrud; Peter Huckfeldt; Roy W Beck; Terri H Lipman Journal: Pediatrics Date: 2015-03 Impact factor: 7.124
Authors: G Todd Alonso; Alex Coakley; Laura Pyle; Katherine Manseau; Sarah Thomas; Arleta Rewers Journal: Diabetes Care Date: 2019-10-10 Impact factor: 19.112
Authors: Andrew J Karter; Melissa M Parker; Matthew D Solomon; Courtney R Lyles; Alyce S Adams; Howard H Moffet; Mary E Reed Journal: Health Serv Res Date: 2017-05-05 Impact factor: 3.402
Authors: Ruth S Weinstock; Dongyuan Xing; David M Maahs; Aaron Michels; Michael R Rickels; Anne L Peters; Richard M Bergenstal; Breanne Harris; Stephanie N Dubose; Kellee M Miller; Roy W Beck Journal: J Clin Endocrinol Metab Date: 2013-06-12 Impact factor: 5.958
Authors: Valentino Cherubini; Julia M Grimsmann; Karin Åkesson; Niels H Birkebæk; Ondrej Cinek; Klemen Dovč; Rosaria Gesuita; John W Gregory; Ragnar Hanas; Sabine E Hofer; Reinhard W Holl; Craig Jefferies; Geir Joner; Bruce R King; Elizabeth J Mayer-Davis; Alexia S Peña; Birgit Rami-Merhar; Ulrike Schierloh; Torild Skrivarhaug; Zdenek Sumnik; Jannet Svensson; Justin T Warner; Nataša Bratina; Dana Dabelea Journal: Diabetologia Date: 2020-05-08 Impact factor: 10.460
Authors: Kevin T Nguyen; Nicole Y Xu; Jennifer Y Zhang; Trisha Shang; Ananda Basu; Richard M Bergenstal; Kristin Castorino; Kong Y Chen; David Kerr; Suneil K Koliwad; Lori M Laffel; Nestoras Mathioudakis; L Kurt Midyett; Joshua D Miller; James H Nichols; Francisco J Pasquel; Priya Prahalad; Mark R Prausnitz; Jane Jeffrie Seley; Jennifer L Sherr; Elias K Spanakis; Guillermo E Umpierrez; Amisha Wallia; David C Klonoff Journal: J Diabetes Sci Technol Date: 2021-10-04
Authors: Kelly R Bergmann; Amanda Nickel; Matt Hall; Gretchen Cutler; M Jennifer Abuzzahab; Brianna Bretscher; Shea Lammers; Dave Watson; Gabrielle Z Hester Journal: JAMA Netw Open Date: 2022-05-02